Circulating tumour cells and survival of patients with gastric cancer

Anticancer Res. 2007 Jan-Feb;27(1B):635-40.

Abstract

Background: The prognostic significance of the presence of tumour cells in the blood of gastric cancer patients remains unclear. Their occurrence and its association with the stage of disease and long-term survival was determined.

Patients and methods: Fifty-seven patients with stage I-IV gastric cancer were divided into two groups: these with and these without circulating tumour cells that were identified as cytokeratin positive (CK+) cells among CD45- cells (obtained by sorting of CD45+ leukocytes).

Results: Tumour cells were detected prior surgery in the peripheral blood of 54.4% patients but no clear association with the stage of disease was observed. After gastrectomy detection rate was 21.1%. There was no significant difference in the 5-year survival of patients, with or without CK+ in the blood.

Conclusion: The presence of circulating tumour cells is of no prognostic value in patients with resectable gastric cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Female
  • Flow Cytometry
  • Gastrectomy
  • Humans
  • Keratins / analysis
  • Leukocyte Common Antigens / analysis
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Neoplastic Cells, Circulating / chemistry
  • Neoplastic Cells, Circulating / pathology*
  • Stomach Neoplasms / blood
  • Stomach Neoplasms / pathology*
  • Stomach Neoplasms / surgery
  • Survival Analysis

Substances

  • Keratins
  • Leukocyte Common Antigens
  • PTPRC protein, human